Home
  >  
Section 54
  >  
Chapter 53,083

Evaluation of the VersaTREK system compared to the Bactec MGIT 960 system for first-line drug susceptibility testing of Mycobacterium tuberculosis

Espasa, M.; Salvadó, M.; Vicente, E.; Tudó, G.; Alcaide, F.; Coll, P.; Martin-Casabona, N.; Torra, M.; Fontanals, D.; González-Martín, J.

Journal of Clinical Microbiology 50(2): 488-491

2012

ISSN/ISBN: 1098-660X
PMID: 22135258
DOI: 10.1128/jcm.06432-11
Accession: 053082937
Download citation:  
Text
  |  
BibTeX
  |  
RIS
The aim of this study was to evaluate the reliability of the VersaTREK system for Mycobacterium tuberculosis drug susceptibility testing compared with results obtained with the Bactec MGIT 960 system. A total of 67 strains were evaluated. Overall agreement was at 98.5%. Kappa indexes were 1.0 for isoniazid, rifampin, and ethambutol, 0.937 for pyrazinamide, and 0.907 for streptomycin. The VersaTREK system is validated for M. tuberculosis drug susceptibility testing.

PDF emailed within 0-6 h: $19.90




Related References

Lin, S.-Y.G.; Desmond, E.; Bonato, D.; Gross, W.; Siddiqi, S. 2009: Multicenter evaluation of Bactec MGIT 960 system for second-line drug susceptibility testing of Mycobacterium tuberculosis complex Journal of Clinical Microbiology 47(11): 3630-3634
Abe, C.; Aono, A.; Hirano, K. 2001: Evaluation of the BACTEC MGIT 960 system for drug susceptibility testing of Mycobacterium tuberculosis isolates compared with the proportion method on solid media Kekkaku: 76(10): 657-662
Rodrigues, C.; Jani, J.; Shenai, S.; Thakkar, P.; Siddiqi, S.; Mehta, A. 2008: Drug susceptibility testing of Mycobacterium tuberculosis against second-line drugs using the Bactec MGIT 960 System International Journal of Tuberculosis and Lung Disease: the Official Journal of the International Union Against Tuberculosis and Lung Disease 12(12): 1449-1455
Garrigó, M.; Aragón, L.M.; Alcaide, F.; Borrell, S.; Cardeñosa, E.; Galán, J.J.é; Gonzalez-Martín, J.án.; Martin-Casabona, N.; Moreno, C.; Salvado, M.; Coll, P. 2007: Multicenter laboratory evaluation of the MB/BacT Mycobacterium detection system and the BACTEC MGIT 960 system in comparison with the BACTEC 460TB system for susceptibility testing of Mycobacterium tuberculosis Journal of Clinical Microbiology 45(6): 1766-1770
Sinirtaş, M.; Ozakin, C.ün.; Gedikoğlu, S. 2009: Evaluation of the fully automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to front line antituberculosis drugs and comparison with the radiometric BACTEC 460 TB method Mikrobiyoloji Bulteni 43(3): 403-409
Zhao, P.; Fang, F.; Yu, Q.; Guo, J.; Zhang, J.-H.; Qu, J.; Liu, Y. 2014: Evaluation of BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to first-line drugs in China Plos one 9(9): E99659
Zhao, L.-l.; Xia, Q.; Lin, N.; Liu, B.; Zhao, X.-q.; Liu, Z.; Wan, K.-l. 2012: Evaluation of BACTEC MGIT 960 system for the second-line drugs susceptibility testing of Mycobacterium tuberculosis in China Journal of Microbiological Methods 91(1): 212-214
Duque, A.; Lin, S.-Y.G.; Desmond, E.; Rienthong, S.; Rienthong, D.; Boonin, C. 2013: Evaluation of the BD Bactec MGIT 320 system for detection of mycobacteria and drug susceptibility testing of Mycobacterium tuberculosis Journal of Clinical Microbiology 51(10): 3403-3405
Gallo, J.F.; Pinhata, J.M.W.; Saraceni, C.P.; de Oliveira, R.S. 2017: Evaluation of the BACTEC MGIT 960 system and the resazurin microtiter assay for susceptibility testing of Mycobacterium tuberculosis to second-line drugs Journal of Microbiological Methods 139: 168-171
Kontos, F.; Nicolaou, S.; Kostopoulos, C.; Gitti, Z.; Petinaki, E.; Maniati, M.; Anagnostou, S.; Raftopoulou, A.; Papageorgiou, P.; Scrioubellou, A.; Tselentis, I.; Maniatis, A.N. 2003: Multicenter evaluation of the fully automated Bactec MGIT 960 system for susceptibility testing of Mycobacterium tuberculosis to pyrazinamide: comparison with the radiometric Bactec 460TB system Journal of Microbiological Methods 55(1): 331-333
Kontos, F.; Maniati, M.; Costopoulos, C.; Gitti, Z.; Nicolaou, S.; Petinaki, E.; Anagnostou, S.; Tselentis, I.; Maniatis, A.N. 2004: Evaluation of the fully automated Bactec MGIT 960 system for the susceptibility testing of Mycobacterium tuberculosis to first-line drugs: a multicenter study Journal of Microbiological Methods 56(2): 291-294
Ardito, F.; Posteraro, B.; Sanguinetti, M.; Zanetti, S.; Fadda, G. 2001: Evaluation of BACTEC Mycobacteria Growth Indicator Tube (MGIT 960) automated system for drug susceptibility testing of Mycobacterium tuberculosis Journal of Clinical Microbiology 39(12): 4440-4444
Sivaramakrishnan, G.; Subramanyam, B.; Kumar, M.P.; Golla, R.; Tripathy, S.P.; Mondal, R. 2019: Validation of bedaquiline drug-susceptibility testing by BACTEC MGIT 960 system for Mycobacterium tuberculosis International Journal of Mycobacteriology 8(4): 329-332
Zhao, L.-L.; Liang, Y.-P.; Huang, M.-X.; Tan, Y.-H.; Jiang, Y.; Chen, Y.; Liu, Z.; Gao, M.; Wei, S.; Chen, Z.; Wu, J.; Jiang, Y.; Wan, K.-L. 2013: Multicenter research on the BACTEC MGIT 960 system for the second-line drugs susceptibility testing of Mycobacterium tuberculosis in China Diagnostic Microbiology and Infectious Disease 77(4): 330-334
Scarparo, C.; Ricordi, P.; Ruggiero, G.; Piccoli, P. 2004: Evaluation of the fully automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide, streptomycin, isoniazid, rifampin, and ethambutol and comparison with the radiometric BACTEC 460TB method Journal of Clinical Microbiology 42(3): 1109-1114
Pfyffer, G.E.; Baker, P.J.; Stashak, P.W.; Amsbaugh, D.F. 2000: Susceptibility testing of Mycobacterium tuberculosis to rifampin and isoniazid BACTEC MGIT 960 vs BACTEC 460 TB System Abstracts of the General Meeting of the American Society for Microbiology 100: 129-130
Kobayashi, I.; Abe, C.; Mitarai, S. 2006: BACTEC MGIT 960 system for drug susceptibility testing of Mycobacterium tuberculosis: a study using external quality assessment strains Kekkaku: 81(2): 57-62
Isaeva, Y.; Bukatina, A.; Krylova, L.; Nosova, E.; Makarova, M.; Moroz, A. 2013: Determination of critical concentrations of moxifloxacin and gatifloxacin for drug susceptibility testing of Mycobacterium tuberculosis in the BACTEC MGIT 960 system Journal of Antimicrobial ChemoTherapy 68(10): 2274-2281
Siddiqi, S.; Ahmed, A.; Asif, S.; Behera, D.; Javaid, M.; Jani, J.; Jyoti, A.; Mahatre, R.; Mahto, D.; Richter, E.; Rodrigues, C.; Visalakshi, P.; Rüsch-Gerdes, S. 2012: Direct drug susceptibility testing of Mycobacterium tuberculosis for rapid detection of multidrug resistance using the Bactec MGIT 960 system: a multicenter study Journal of Clinical Microbiology 50(2): 435-440
Tortoli, E.; Benedetti, M.; Fontanelli, A.; Simonetti, M.Tullia. 2002: Evaluation of automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to four major antituberculous drugs: comparison with the radiometric BACTEC 460TB method and the agar plate method of proportion Journal of Clinical Microbiology 40(2): 607-610